Naber D - Search Results

1

Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics.

Moritz S, Andresen B, Jacobsen D, Mersmann K, Wilke U, Lambert M, Naber D, Krausz M. Moritz S, et al. Among authors: naber d. Eur Psychiatry. 2001 Sep;16(6):354-61. doi: 10.1016/s0924-9338(01)00591-0. Eur Psychiatry. 2001. PMID: 11585716

2

Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia.

Krausz M, Moritz SH, Naber D, Lambert M, Andresen B. Krausz M, et al. Among authors: naber d. Eur Psychiatry. 1999 Apr;14(2):84-8. doi: 10.1016/s0924-9338(99)80722-6. Eur Psychiatry. 1999. PMID: 10572331

3

Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia.

Krausz M, Moritz S, Lambert M, Naber D. Krausz M, et al. Among authors: naber d. Int Clin Psychopharmacol. 2000 Mar;15(2):77-81. doi: 10.1097/00004850-200015020-00003. Int Clin Psychopharmacol. 2000. PMID: 10759338

4

[Conversion from typical to atypical neuroleptics. Guidelines for ambulatory and inpatient treatment].

Lambert M, Moritz S, Haasen C, Naber D. Lambert M, et al. Among authors: naber d. Nervenarzt. 2000 Nov;71(11):859-75. doi: 10.1007/s001150050677. Nervenarzt. 2000. PMID: 11103361 Review. German.

5

Enhanced semantic priming in thought-disordered schizophrenic patients using a word pronunciation task.

Moritz S, Mersmann K, Kloss M, Jacobsen D, Andresen B, Krausz M, Pawlik K, Naber D. Moritz S, et al. Among authors: naber d. Schizophr Res. 2001 Mar 30;48(2-3):301-5. doi: 10.1016/s0920-9964(00)00057-8. Schizophr Res. 2001. PMID: 11295382

6

Subjective cognitive dysfunction in first-episode and chronic schizophrenic patients.

Moritz S, Lambert M, Andresen B, Böthern A, Naber D, Krausz M. Moritz S, et al. Among authors: naber d. Compr Psychiatry. 2001 May-Jun;42(3):213-6. doi: 10.1053/comp.2001.23144. Compr Psychiatry. 2001. PMID: 11349240

7

Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs.

Naber D, Moritz S, Lambert M, Pajonk FG, Holzbach R, Mass R, Andresen B. Naber D, et al. Schizophr Res. 2001 May 30;50(1-2):79-88. doi: 10.1016/s0920-9964(00)00166-3. Schizophr Res. 2001. PMID: 11378316 Clinical Trial.

8

[Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients].

Briken P, Nika E, Krausz M, Naber D. Briken P, et al. Among authors: naber d. Fortschr Neurol Psychiatr. 2002 Mar;70(3):139-44. doi: 10.1055/s-2002-20501. Fortschr Neurol Psychiatr. 2002. PMID: 11880946 Review. German.

9

Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.

Lambert M, Conus P, Eide P, Mass R, Karow A, Moritz S, Golks D, Naber D. Lambert M, et al. Among authors: naber d. Eur Psychiatry. 2004 Nov;19(7):415-22. doi: 10.1016/j.eurpsy.2004.06.031. Eur Psychiatry. 2004. PMID: 15504648

10

Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia.

Karow A, Moritz S, Lambert M, Schöttle D, Naber D; EGOFORS Initiative. Karow A, et al. Among authors: naber d. Eur Psychiatry. 2012 Aug;27(6):401-5. doi: 10.1016/j.eurpsy.2011.01.012. Epub 2011 May 12. Eur Psychiatry. 2012. PMID: 21570262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters